Results 61 to 70 of about 5,822 (192)

Ophthalmological evaluation in thyroid‐associated ophthalmopathy [PDF]

open access: yesActa Ophthalmologica Scandinavica, 2003
Abstract.Purpose:  Thyroid‐associated ophthalmopathy (TAO) is an autoimmune disorder associated with Graves' disease and can seriously decrease quality of life. Current therapeutic regimens have considerable side‐effects and are not always able to restore normal function and appearance.
openaire   +2 more sources

Optical coherence tomography angiography in thyroid associated ophthalmopathy: a systematic review

open access: yesBMC Ophthalmology
Purpose To evaluate the evidence for alterations of blood flow, vascular and perfusion densities in the choroid, macula, peripapillary region, and the area surrounding the optic nerve head (ONH) in patients with thyroid-associated ophthalmopathy (TAO ...
Mohammad Taher Rajabi   +6 more
doaj   +1 more source

Managing Nasal Ischemia and Necrosis Post‐Triamcinolone Injection: A New Case Series

open access: yesCase Reports in Otolaryngology, Volume 2026, Issue 1, 2026.
Nasal ischemia following cosmetic injections has been reported in several cases. Postsurgery triamcinolone administration in the nasal region is a common practice to reduce inflammation and address pollybeak deformity. While cases of retinal artery occlusion following triamcinolone injection have been documented, this case series presents the first ...
Shahriar Nazari   +7 more
wiley   +1 more source

Tissue eosinophilia and eosinophil degranulation in Riedel's invasive fibrous thyroiditis. [PDF]

open access: yes, 1996
The etiology of Riedel's invasive fibrous thyroiditis (IFT) has remained obscure. This rare disorder has been confused in the past with the more common fibrous variant of Hashimoto's disease.
A. E. Heufelder   +9 more
core   +1 more source

Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development

open access: yesTaiwan Journal of Ophthalmology, 2020
Thyroid-associated ophthalmopathy (TAO) is the most common extrathyroidal manifestation of toxic diffuse goiter (Graves' disease), also known as Graves' ophthalmopathy/orbitopathy. As an organ-specific autoimmune disease, the pathogenesis of TAO is still
Yazhuo Huang   +3 more
doaj   +1 more source

Differential Diagnosis of Thyroid Dermopathy and Acropachy with Arthritis

open access: yesTürk Osteoporoz Dergisi, 2021
Thyroid acropachy is a rare manifestation of autoimmune thyroid disease with characteristic imaging findings. Clinically, it is almost always associated with thyroid ophthalmopathy and dermopathy.
Nurdan Yılmaz, Pelin Gümüş Ok
doaj   +1 more source

Exploring the Therapeutic Mechanism of Xiehuo Pingtu San in Treating Thyroid Eye Disease Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Xiehuo Pingtu San (XHPTS) has been shown to be safe and effective in treating thyroid eye disease (TED), yet its underlying mechanisms remain unclear. This study aimed to elucidate the active ingredients of XHPTS and their therapeutic mechanisms in TED through network pharmacology, molecular docking, and molecular dynamics simulations ...
Ping Wang   +6 more
wiley   +1 more source

Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy [PDF]

open access: yes, 1988
A 64 kDa protein has been identified in the membrane fraction of human eye muscle, orbital connective tissue and thyroid, by testing sera of patients with thyroid-associated ophthalmopathy in SDS-polyacrylamide gel electrophoresis and Western blotting ...
M. Salvi   +5 more
core   +1 more source

Quantitative MRI Assessment of Orbital Structures in Radioactive Iodine‐131 Therapy for Inactive Graves’ Ophthalmopathy

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Objective The understanding regarding the role of orbital magnetic resonance imaging (MRI) in predicting the prognosis of radioactive iodine‐131 (I‐131) therapy for patients with inactive Graves’ ophthalmopathy (GO) is limited. Therefore, this study aimed to explore the application of MRI quantitative measurements of orbital structures in radioactive I‐
Man Wang   +3 more
wiley   +1 more source

Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Thyroid eye disease (TED) is an autoimmune inflammatory condition linked to thyroid dysfunction, which can result in disfigurement and potential vision loss. Recently, immunomodulatory therapies such as rituximab have demonstrated potential benefit in managing TED.
Ming Lu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy